Andre Fabien MD in Willoughby, Ohio

Home Ohio Willoughby

Andre Fabien MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 36001 Euclid Ave in Willoughby, Ohio.

They're a part of the: Gary B. Kaplan, M.d.,inc. medical group which has around 7 members. You can call their office at 440-946-0053 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Andre M Fabien MD Office Phone and Directions

Andre Fabien MD
Gary B. Kaplan, M.d.,inc.
36001 Euclid Ave
Willoughby, Ohio 44094
440-946-0053

Patient Ratings
Please rate your experience with Andre Fabien MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 440-946-0053

Enter a starting address:

Healthcare Info for Andre Fabien MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University
Graduation Year: 2003
The Primary Medical Specialty for Andre Fabien MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 21
PAC (PECOS ID)#: 4082718309
NPI #: 1689758229
NPI Created On: 10/24/2006
NPI Last Updated Listed as: 01/26/2008
Primary Taxonomy Code: 207R00000X
License Number:
35-088788
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Ambetter
MOLINA HEALTHCARE OF OHIO
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Determination of lung volumes using gas dilution or washout
Determination of lung volumes using gas dilution or washout
Measurement of lung diffusing capacity
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801689747

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801690155

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801690271

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801690867

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801692479

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801695051

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801920297

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801924305

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801998353

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802158203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Pulmonary Disease Professionals in Willoughby

1.
Gary Kaplan MD

36001 Euclid Ave
Willoughby, OH
Gary B. Kaplan, M.d.,inc.

Providers in Gary B. Kaplan, M.d.,inc.

1.Russell Blair

36001 Euclid Ave
Willoughby Oh 44094-4643
Gary B. Kaplan, M.d.,inc.
Hospitalist

2.Andre Fabien Md

36001 Euclid Ave
Willoughby Oh 44094-4643
Gary B. Kaplan, M.d.,inc.
Pulmonary Disease

3.Jeffrey Jordan

36001 Euclid Ave
Willoughby Oh 44094-4643
Gary B. Kaplan, M.d.,inc.
Nurse Practitioner

4.Gary Kaplan Md

36001 Euclid Ave
Willoughby Oh 44094-4643
Gary B. Kaplan, M.d.,inc.
Pulmonary Disease

5.Lisa Kuhen Np

36001 Euclid Ave
Willoughby Oh 44094-4643
Gary B. Kaplan, M.d.,inc.
Nurse Practitioner

6.Pamela Petro

36001 Euclid Ave
Willoughby Oh 44094-4643
Gary B. Kaplan, M.d.,inc.
Nurse Practitioner

View all 7 members of Gary B. Kaplan, M.d.,inc. medical group